Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey

Simon J Otter, Sunil Kumar, Peter Gow, Nicola Dalbeth, Michael Corkill, Maheswaran Rohan, Kevin A Davies, Sam Pankathelam, Keith Rome, Simon J Otter, Sunil Kumar, Peter Gow, Nicola Dalbeth, Michael Corkill, Maheswaran Rohan, Kevin A Davies, Sam Pankathelam, Keith Rome

Abstract

Background: Foot complaints are common in inflammatory arthropathies such as rheumatoid arthritis and cause considerable disability. However, little is published about the nature and extent of foot complaints in systemic lupus erythematosus (SLE). We aimed to explore foot complaints among people with (SLE) and to evaluate the associations between foot pain and self-reported activities of daily living and well-being.

Methods: We developed and tested a new 40-item item self-administered questionnaire, using a five-stage development process utilising patient involvement throughout to ensure face and content validity. The self-administered instrument was posted to 406 people with SLE attending adult rheumatology clinics across three health boards in Auckland, New Zealand. The questionnaire enquired about symptoms of foot pain, extra-articular features, anatomical distribution of symptoms according to validated foot-mannequins and the impact of foot symptoms on activities of daily living and well-being.

Results: In total, 406 questionnaires were posted, with 131 responses (response rate 32 %). We found 89 % were women, mean (SD) age 51 (15) years, mean (SD) diagnosis 12.5 (11.1) years. Overall, 77 % of those responding to the questionnaire reported foot pain during their SLE, with 45 % reporting current foot pain. All regions of the feet were affected, with the hindfoot (32 %) and ankles (30 %) most troublesome. The most common self-reported extra-articular foot complaints were cold feet, swelling and numbness. Almost two-thirds (61 %) reported foot pain adversely affected their lives; foot pain prevented sleeping in 36 % and had a negative effect on emotions for 33 %. Only 33 % of participants had seen a podiatrist. Significant association was found between foot pain and standing longer than 15 min (p < 0.001), walking (p < 0.001), climbing stairs (p < 0.001) and going shopping (p < 0.001). Pain was the primary symptom to affect quality of life (47/100).

Conclusion: Foot complaints in SLE are heterogeneous in nature, and may have a substantial negative impact on patient well-being. Foot complaints need to be addressed to reduce the burden of SLE and our findings support the need for wider access to specific foot care services.

Keywords: Disability; Foot; Impairment; Pain; Quality of life; Systemic lupus erythematosus.

Figures

Fig. 1
Fig. 1
Frequency of pain reported by patients within different time descriptors at different anatomical sites in the foot. a Frequency of pain reported ever during the course of the disease at different anatomical sites in the foot. b Frequency of pain reported in the last month at different anatomical sites in the foot. c Frequency of pain reported today at different anatomical sites in the foot

References

    1. D’Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet. 2007;369:587–96. doi: 10.1016/S0140-6736(07)60279-7.
    1. Choi J, Kim ST, Craft J. The pathogenesis of systemic lupus erythematosus—an update. Curr Op Immunol. 2012;24:651–7. doi: 10.1016/j.coi.2012.10.004.
    1. Mosca M, Boumpas D, Bruce IN, Cervera R, Czirjak L, Dörner T, et al. Treat to target in system lupus erythematosus: where are we today? Clin Exp Rheumatol. 2012;30:S112–5.
    1. Lateef A, Petri M. Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther. 2012;14:S4. doi: 10.1186/ar3919.
    1. Panopalis P, Clarke AE, Yelin E. The economic burden of systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2012;26:695–704. doi: 10.1016/j.berh.2012.08.006.
    1. Hart HH, Grigor RR, Caughey DE. Ethnic difference in the prevalence of systemic lupus erythematosus. Ann Rheum Dis. 1983;42:529–32. doi: 10.1136/ard.42.5.529.
    1. Reilly PA, Evison G, McHugh NJ, Maddison PJ. Arthropathy of hands and feet in systemic lupus erythematosus. J Rheumatol. 1990;17:777–84.
    1. Iagnocco A, Ceccarelli F, Rizzo C, Truglia S, Massaro L, Spinelli FR, et al. Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus. Rheumatology (Oxford) 2014;53:465–72. doi: 10.1093/rheumatology/ket376.
    1. Cervera R. Systemic Lupus Erythematosus in Europe at the change of the millennium: Lessons from the “Euro-Lupus Project”. Autoimmun Rev. 2006;5:180–6. doi: 10.1016/j.autrev.2005.06.004.
    1. Mizutani W, Francisco P, Quismorio JR. Lupus foot: deforming arthropathy of the feet in systemic lupus erythematosus. J Rheumatol. 1984;11:80–2.
    1. Bhatt SP, Handa R, Gulati GS, Sharma S, Pandey RM, Aggarwal P, et al. Peripheral vascular disease in systemic lupus erythematosus. Lupus. 2007;16:720–3. doi: 10.1177/0961203307081123.
    1. Koeing KF, Ribi C, Radosavac H, Zulewski H, Trendelenburg M. Swiss SLE cohort study prevalence of vascular disease in systemic lupus erythematosus compared with type-1 diabetes mellitus: a cross sectional study of two cohorts. Lupus. 2015;24:58–65. doi: 10.1177/0961203314550223.
    1. Theodoridou A, Bento L, D’Curz DP, Khamashta MA, Hughes GRV. Prevalence and associations of an abnormal ankle-brachial index in systemic lupus erythematosus: a pilot study. Ann Rheum Dis. 2003;62:1199–203. doi: 10.1136/ard.2002.001164.
    1. Erdozcain JG, Villar I, Nieto J, Ruiz-Irastorza G. Peripheral arterial disease in systemic lupus erythematosus: prevalence and risk factors. J Rheumatol. 2014;41:310–7. doi: 10.3899/jrheum.130817.
    1. Jeffery RC, Narshi CB, Isenberg DA. Prevalence, serological features, response to treatment and outcome of critical peripheral ischaemia in a cohort of lupus participants. Rheumatology. 2008;47:1379–83. doi: 10.1093/rheumatology/ken210.
    1. Liu A, Zhang W, Tian X, Zhang X, Zhang F, Zeng X. Lupus around the world: prevalence, risk factors and outcome of digital gangrene in 2684 lupus participants. Lupus. 2009;18:1112–8. doi: 10.1177/0961203309106643.
    1. Williams AE, Crofts G, Teh LS. ‘Focus on feet’–the effects of systemic lupus erythematosus: a narrative review of the literature. Lupus. 2013;22:1017–23. doi: 10.1177/0961203313498805.
    1. Petri M, Orbai A-M, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–86. doi: 10.1002/art.34473.
    1. Chatterton BD, Muller S, Thomas MJ, Menz HB, Rome K, Roddy E. Inter and intra-rater reliability of the scoring of foot drawings. J Foot Ankle Res. 2013;6:44. doi: 10.1186/1757-1146-6-44.
    1. McElhone K, Abbott J, Shelmerdine J, Bruce IN, Ahmad Y, Gordon C, et al. Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum. 2007;57:972–9. doi: 10.1002/art.22881.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative: the strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007;18:800–4. doi: 10.1097/EDE.0b013e3181577654.
    1. Font J, Cervera R, Ramos-Casals M, García-Carrasco M, Sents J, Herrero C, et al. Clusters of clinical and immunologic features in systemic lupus erythematous: analysis of 600 participants from a single centre. Sem Arthritis Rheum. 2004;33:217–30. doi: 10.1053/S0049-0172(03)00133-1.
    1. Rothfield N, Sontheimer RD, Berstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24:348–62. doi: 10.1016/j.clindermatol.2006.07.014.
    1. Otter SJ, Lucas K, Springett K, Moore A, Davies K, Cheek L. Foot pain in rheumatoid arthritis prevalence and risk factors & management: an epidemiological study. Clin Rheumatol. 2010;29:255–71. doi: 10.1007/s10067-009-1312-y.
    1. Hyslop E, McInnes IB, Woodburn J, Turner DE. Foot problems in psoriatic arthritis: high burden and low care provision. Ann Rheum Dis. 2010;69:928. doi: 10.1136/ard.2009.111971.
    1. Alcacer-Pitarch B, Siddle HJ, Buch MH, Emery P, Hashmi F, Redmond AC. Foot health needs in people with systemic sclerosis: an audit of foot health care provision. Clin Rheumatol. 2011;10:1611–5. doi: 10.1007/s10067-011-1784-4.
    1. Scofield L, Reinlib L, Alarcón GS, Cooper GS. Employment and disability issues in systemic lupus erythematosus: a review. Arthritis Rheum. 2008;59:1475–9. doi: 10.1002/art.24113.
    1. Mancuso CA, Pena M, Sargent AB, Salmon JE. Perceptions and measurements of physical activity in participants with systemic lupus erythematosus. Lupus. 2010;10:1–12.
    1. Oomatia A, Fang H, Petri M, Birnbaum J. Peripheral neuropathies in systemic lupus erythematosus: clinical features, disease associations, and immunologic characteristics evaluated over a twenty-five-year study period. Arthritis Rheum Dis. 2014;66:1000–9. doi: 10.1002/art.38302.
    1. Florica B, Aghdassi E, Su J, Gladman DD, Urowitz MB, Fortin PR. Peripheral neuropathy in participants with systemic lupus erythematosus. Sem Arthritis Rheum. 2011;41:203–11. doi: 10.1016/j.semarthrit.2011.04.001.
    1. Gronhagen CM, Gunnarsson I, Svenungsson E, Nyberg F. Cutaneous manifestations and serological findings in 260 participants with systemic lupus erythematosus. Lupus. 2010;19:1187–94. doi: 10.1177/0961203310367656.
    1. Yell JA, Mbuagbaw J, Burge SM. Cutaneous manifestations of systemic lupus erythematosus. Br J Dermatol. 1996;135:355–62. doi: 10.1111/j.1365-2133.1996.tb01495.x.
    1. Sanders C, Van Weelden H, Kazzaz G, Sigurdsson V, Toonstra J, Bruijnzeel-Koomen CA. Photosensitivity in participants with lupus erythematosus: a clinical and photobiological study of 100 participants using a prolonged phototest protocol. Br J Dermatol. 2003;149:131–7. doi: 10.1046/j.1365-2133.2003.05379.x.
    1. Firth J, Hale C, Helliwell PS, Hill J, Nelson EA. The prevalence of foot ulceration in participants with rheumatoid arthritis. Arthritis Care Res. 2008;59:200–5. doi: 10.1002/art.23335.
    1. Standards of Care for people with musculoskeletal foot health problems Accessed 29.9.2015 Available from:
    1. Arthritis and Musculoskeletal Alliance, UK, 2007 Standards of Care for people with Connective Tissue Disorders Internet Accessed 29.9.2015 Available from:
    1. Hennessy K, Woodburn J, Steultjens MP. Custom foot orthoses for rheumatoid arthritis: a systematic review. Arthritis Care Res. 2012;64:311–20. doi: 10.1002/acr.21559.
    1. Brenton-Rule A, Hendry G, Barr G, Rome K. An evaluation of seasonal variations in footwear worn by adults with inflammatory arthritis: a cross-sectional observational study using a web-based survey. J Foot Ankle Res. 2014;7:36. doi: 10.1186/s13047-014-0036-7.
    1. Wilson O, Briggs W, Hewlett S, Pollock J, Woodburn J, Quest E, et al. Does self-report of foot problems agree with clinical examination in people with rheumatoid arthritis? Ann Rheum Dis. 2015;74(Suppl 2):106.2. doi: 10.1136/annrheumdis-2015-eular.1709.
    1. Rome K, Gow P, Erickson K, Ng A, Sahid H, Williams AE. Meeting the demands of a podiatry service for patients with arthritis. NZ Med J. 2013;126:1–8.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir